Indian multinational pharmaceutical company, Zydus Lifesciences Limited, has received final approval from the United States ...

Indian multinational pharmaceutical company, Zydus Lifesciences Limited, has received final approval from the United States ...

Zydus Lifesciences Limited has earned USFDA approval for Niacin Extended-Release Tablets used to treat high cholesterol.

Jaiprakash Associates faces corporate insolvency with 25 bidders vying for acquisition, including major Indian conglomerates ...

BHOPAL: Three male elephants have been on a destructive spree in around 30 villages in Anuppur, Jaithari and Rajendragram ...

Pennington: Zydus Lifesciences' venture capital arm, Zynext Ventures USA LLC, has announced its investment in Feldan ...

The approval includes various strengths of Jaythari, 6 mg, 18 mg, 30 mg, and 36 mg, which adds to Zydus’ portfolio of products in the US generic pharma market. Jaythari is indicated for the ...

Zydus will now manufacture Jaythari® (Deflazacort) Tablets in 6 mg, 18 mg, 30 mg, and 36 mg. Deflazacort is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy in patients 5 ...

Zydus Lifesciences: The pharma major has got final approval from the United States Food and Drug Administration (USFDA) to manufacture Jaythari (Deflazacort) tablets. Ashoka Buildcon: The highway ...

Additionally, Zydus has received the final nod from the US FDA for its Jaythari (Deflazacort) Tablets in various strengths, which could drive its growth in the pharmaceutical market. HCLTech has ...